Total:82
-
2022-04-18 19:00
Over 161m doses of COVID vaccine imported
TEHRAN – Iran has so far imported more than 161,933,728 doses of vaccine to combat the coronavirus pandemic.
-
2022-03-12 17:36
Iranian mRNA vaccine to start clinical trial
TEHRAN – The Iranian mRNA vaccine for coronavirus has received permission from the Food and Drug Administration to enter phase one of the human trials, said a member of the scientific committee of the National Headquarters for Coronavirus Control.
-
2022-03-08 20:51
West Asia’s largest COVID-19 vaccine plant inaugurated in Iran
TEHRAN – Iran on Tuesday officially inaugurated a coronavirus vaccine production unit which is said to be the largest of its kind in West Asia.
-
2022-03-01 18:07
“Noora” vaccine receives emergency use license
TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), has received an emergency use license.
-
2022-02-20 18:39
76% of students aged 12-18 inoculated
TEHRAN – Some 76 percent of the students aged 12-18 years have received the second dose of the COVID-19 vaccine, according to the latest announcement of the Ministry of Education.
-
2022-02-18 17:36
“Noora” vaccine produces strong neutralizing antibodies: study
TEHRAN – The results of the first and second phases of the clinical trial showed that “Noora” vaccine produces very strong neutralizing antibodies against coronavirus.
-
2022-01-14 17:08
Spikogen vaccine approved for third dose injection
TEHRAN – The Food and Drug Administration on Thursday authorized Spikogen coronavirus vaccines as a booster dose of all vaccines, deputy health minister Kamal Heydari has said.
-
2022-01-04 16:18
Intl. journals publish seven articles on Iran-Cuba vaccine
TEHRAN – Seven articles on different stages of development and clinical trials of the Iranian-Cuban coronavirus vaccine have been published in prestigious international journals.
-
2022-01-02 17:11
IRGC’s “Noora” vaccine begins third phase of human trial
TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), entered the third phase of the human trial on Sunday.
-
2021-12-31 17:04
Negotiations underway to export Razi Cov Pars vaccine
TEHRAN – A number of countries have requested to purchase the Iranian-made Cov Pars vaccine for COVID-19, and negotiations are underway to take the necessary measures for export, vice president for research and technology of Razi Vaccine and Serum Research Institute, said.
-
2021-11-23 17:59
Iran outpaces Europe in first-dose COVID-19 vaccination
TEHRAN – The national average for the first dose vaccination of people over the age of 12 was 82 percent in Iran, while it was 64 percent in Europe, Mohammad Mehdi Gooya, head of the diseases management center of the Ministry of Health, said.
-
2021-11-12 17:12
COVIRAN vaccine to begin clinical trial on children aged 12-18
TEHRAN – COVIRAN BAREKAT vaccine received a license to start a clinical trial on children aged 12 to 18 by the next week, Minoo Mohraz, a member of the National Scientific Committee of COVID-19, has said.
-
2021-11-07 17:39
Monthly COVID-19 vaccine output reaches 10m doses
TEHRAN – The domestic manufacturers of coronavirus vaccine have managed to increase their monthly production to 10 million doses, Seyed Heydar Mohammadi, an official with the Food and Drug Administration, has said.
-
2021-11-06 16:38
Some 24% of students vaccinated nationwide
TEHRAN – A total of 1,572,380 students, equaling 24 percent of the target group aged 12 to 18 nationwide, have received both doses of coronavirus vaccine, Azam Goudarzi, a health ministry official, said on Saturday.
-
2021-10-25 19:00
S. Korea to provide Iran with 1m doses of COVID vaccine
TEHRAN - South Korea will soon offer 1 million doses of AstraZeneca vaccine to Iran, on humanitarian grounds, to help address its vaccine shortage, Seoul's foreign ministry said Monday.
-
2021-10-12 17:53
Nasal dose of COV Pars reduces virus transmission by 90%
TEHRAN – The inhaled dose of COV Pars vaccine reduces the transmission of delta and alpha coronavirus variants by up to 90 percent, Ali Es’haqi, head of Razi Vaccine and Serum Institute, has said.
-
2021-10-08 17:22
Spikogen vaccine licensed for emergency use
TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.
-
2021-09-13 17:16
Fakhra vaccine enters third phase of human test
TEHRAN – The third phase of the Fakhra vaccine’s human trial started on Monday by being administrated to 40,000 volunteers, IRIB reported.
-
2021-09-08 18:16
Pastu Covac vaccine approved for children under 18
TEHRAN – Pastu Covac, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only homegrown vaccine that includes use in children aged under 18.
-
2021-09-05 18:17
Cov Pars begins third phase of clinical studies
TEHRAN – “Razi Cov Pars” vaccine entered on Sunday the third phase of the human trial, being administrated to 40,000 people, IRIB reported.
-
2021-08-07 19:47
Spikogen vaccine enters third phase of clinical trial
TEHRAN – The Iranian-Australian coronavirus vaccine Spikogen started the third phase of the clinical trial with the participation of 17,000 people on Saturday.
-
2021-08-01 17:06
More 200,000 doses of COVIRAN vaccine delivered
TEHRAN – Some 200,000 doses of COVIRAN BAREKAT vaccine have been recently delivered to the Ministry of Health for public vaccination, Hassan Jalili, the vaccine’s production manager, said on Sunday.
-
2021-07-31 17:12
“Noora” vaccine successfully passing first phase of clinical trial
TEHRAN – “Noora" coronavirus vaccine, domestically made by Baqiyatallah University of Medical Sciences affiliated to the Islamic Revolution Guard Corps (IRGC), is successfully passing the first phase of the clinical trial.
-
2021-07-26 20:00
Cov Pars to produce 1m doses of vaccine monthly
TEHRAN – One million doses of “Razi Cov Pars” vaccine will be produced each month as of the sixth calendar month Shahrivar (starting August 23), Mohammad-Hassan Fallah Mehrabadi, deputy head of the Razi Vaccine and Serum Research Institute has announced.
-
2021-07-25 16:06
COVIRAN BAREKAT in process to WHO’s registration
TEHRAN – COVIRAN BAREKAT, the first Iranian-made coronavirus vaccine, is in the process to be registered by the World Health Organization, Asghar Abdoli, an expert in the vaccine production project, has stated.
-
2021-07-25 16:05
Pastu Covac is world’s only vaccine targeting several mutations: expert
TEHRAN – Pastu Covac coronavirus vaccine, developed jointly by the Pasteur Institute of Iran and Cuba's Finlay Vaccine Institute, is the only vaccine in the world that can fight several mutations simultaneously, Alireza Biglari, head of the Pasteur Institute, has said.
-
2021-07-18 16:54
COVIRAN vaccine beats Delta variant
TEHRAN – COVIRAN BAREKAT coronavirus vaccine proved effective against Indian strain, Hojjat Niki-Maleki head of the information center of Headquarters for Executing the Order of the Imam twitted on Saturday.
-
2021-07-16 21:53
Pastu Covac neutralizes new COVID-19 strains
TEHRAN – Preliminary results of studies show that the Pastu Covac coronavirus vaccine, developed by the Pasteur Institute of Iran, fights very well against new variants of South Africa and India, and in other words, neutralizes them, Alireza Biglari, head of the Pasteur Institute, has said.
-
2021-07-10 17:08
Tehran-Havana strategic cooperation on coronavirus vaccine production
TEHRAN – The long history of cooperation between Iran and Cuba in biotechnology has led to a strategic relationship to develop a COVID-19 vaccine to fight against the global pandemic.
-
2021-06-27 16:49
Iran among few countries with all vaccine production platforms
TEHRAN – Iran is one of the few countries that has all vaccine production platforms, Mohammad Reza Shanehsaz, head of the Iranian Food and Drug Administration, has stated.
